Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline is a research paper published in JAC-Antimicrobial Resistance (2024). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: K23 AI154546
NHLBI NIH HHS
Grant: R03 HL162655
National Institutes of Health
Grant: 5R21AI151363-02
Use of site-specific pharmacokinetics to optimize antibiotic combinations and prevent the emergence of resistance against CRE
National Institutes of Health
Grant: 5R03HL162655-02
Microbial Determinants of Acute Respiratory Distress Syndrome Severity (MiDAS)
National Institutes of Health
Grant: 1K23AI154546-01A1
The Gut Microbiome in Carbapenem-Resistant Enterobacteriaceae Colonization, Persistence, Infection, and Tolerance after Lung or Liver Transplantation
National Institutes of Health
National Heart, Lung, Blood Institute of the National Institutes of Health
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Fields of Study
Keywords